Patent · US Active

Triterpene saponin analogues

US10906926B2 · kind B2 · utility

3Cited by

18References

21Claims

0Family size

Assignees

ADJUVANCE TECHNOLOGIES, INC. · US
Memorial Sloan Kettering Cancer Center · US

Inventors

David Y. Gin · New York, US
Eric CHEA · Great Neck, US
Alberto Fernandez-Tejada · Kingston, US
Jeffrey GARDNER · New York, US
Jason S. Lewis · New York, US
Philip O. Livingston · New York, US
J. Tyler MARTIN · Roca, US
Lars NORDSTROEM · New York, US
Naga Vara Kishore Pillarsetty · New York, US
Govind Ragupathi · New York, US
Derek Shieh Tan · New York, US

Key dates

Filing date	Mar 23, 2020
Grant date	Feb 2, 2021
Priority date	—
Expiry date	Apr 14, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.